These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 9859529)
1. [The effect of antenatal corticosteroid prophylaxis in premature newborns with the use of surfactant therapy]. Iarŭkova N; Nikolov A; Dimitrov A; Chernev T; Iarŭkov A Akush Ginekol (Sofiia); 1998; 37(2):20-3. PubMed ID: 9859529 [TBL] [Abstract][Full Text] [Related]
2. [The use of Curosurf with premature infants--the prevention or treatment of the neonatal RDS]. Iarŭkova N; Chernev T; Nikolov A Akush Ginekol (Sofiia); 1998; 37(3):12-4. PubMed ID: 10204257 [TBL] [Abstract][Full Text] [Related]
3. [Effect from surfactant therapy in extremely low birth weight infants depending on the method of delivery]. Iarŭkova N; Nikolov A; Slŭncheva B; Vakrilova L; Pramatarova T; Dimitrov A Akush Ginekol (Sofiia); 2007; 46(3):31-5. PubMed ID: 18018780 [TBL] [Abstract][Full Text] [Related]
4. Combined effects of antenatal corticosteroids and surfactant supplementation on the outcome of very low birth weight infants. Modanlou HD; Beharry K; Padilla G; Iriye B J Perinatol; 1996; 16(6):422-8; quiz 429-30. PubMed ID: 8979178 [TBL] [Abstract][Full Text] [Related]
5. [Administration of exogenous surfactant in premature very low birth weight infants with RDS]. Iarŭkova N; Vakrilova L; Slŭncheva B; Dancheva S; Popivanova A; Emilova Z; Dimitrov A; Chernev T; Nikolov A Akush Ginekol (Sofiia); 1999; 38(1):23-6. PubMed ID: 11965714 [TBL] [Abstract][Full Text] [Related]
6. Incidence of respiratory disorders in neonates born between 34 and 36 weeks of gestation following exposure to antenatal corticosteroids between 24 and 34 weeks of gestation. Ventolini G; Neiger R; Mathews L; Adragna N; Belcastro M Am J Perinatol; 2008 Feb; 25(2):79-83. PubMed ID: 18188800 [TBL] [Abstract][Full Text] [Related]
7. Comparison of prophylaxis and rescue treatment with Curosurf in neonates less than 30 weeks' gestation: a randomized trial. Egberts J; de Winter JP; Sedin G; de Kleine MJ; Broberger U; van Bel F; Curstedt T; Robertson B Pediatrics; 1993 Dec; 92(6):768-74. PubMed ID: 8233735 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of a single dose of antenatal corticosteroids on morbidity and mortality of preterm infants. Costa S; Zecca E; De Luca D; De Carolis MP; Romagnoli C Eur J Obstet Gynecol Reprod Biol; 2007 Apr; 131(2):154-7. PubMed ID: 16797825 [TBL] [Abstract][Full Text] [Related]
9. [Prevention of the neonatal lung immaturity]. Zhekova N; Mikhova M; Nikolov A; Dimitrov A Akush Ginekol (Sofiia); 2009; 48(1):11-5. PubMed ID: 19496457 [TBL] [Abstract][Full Text] [Related]
10. A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome. Sinha SK; Lacaze-Masmonteil T; Valls i Soler A; Wiswell TE; Gadzinowski J; Hajdu J; Bernstein G; Sanchez-Luna M; Segal R; Schaber CJ; Massaro J; d'Agostino R; Pediatrics; 2005 Apr; 115(4):1030-8. PubMed ID: 15805381 [TBL] [Abstract][Full Text] [Related]
11. Antenatal corticosteroid therapy in premature infants. Smrcek JM; Schwartau N; Kohl M; Berg C; Geipel A; Krapp M; Diedrich K; Ludwig M Arch Gynecol Obstet; 2005 Jan; 271(1):26-32. PubMed ID: 15309401 [TBL] [Abstract][Full Text] [Related]
12. [Prenatal steroids for fetal maturation in preterm birth. Experience at an institution]. Arroyo Cabrales LM; Guzmán Bárcenas J Ginecol Obstet Mex; 2000 Nov; 68():448-52. PubMed ID: 11195957 [TBL] [Abstract][Full Text] [Related]
13. [Protective and curative effects of prophylactic administration of pulmonary surfactant on neonatal respiratory distress syndrome]. Chu GL; Wang J; Xin Y; Zheng J; Zheng RX; Bi DZ Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(13):876-80. PubMed ID: 16759511 [TBL] [Abstract][Full Text] [Related]
14. Observational study to compare the clinical efficacy of the natural surfactants Alveofact and Curosurf in the treatment of respiratory distress syndrome in premature infants. Proquitté H; Dushe T; Hammer H; Rüdiger M; Schmalisch G; Wauer RR Respir Med; 2007 Jan; 101(1):169-76. PubMed ID: 16698258 [TBL] [Abstract][Full Text] [Related]
15. An observational study of surfactant treatment in infants of 23-30 weeks' gestation: comparison of prophylaxis and early rescue. Bevilacqua G; Parmigiani S; J Matern Fetal Neonatal Med; 2003 Sep; 14(3):197-204. PubMed ID: 14694975 [TBL] [Abstract][Full Text] [Related]
16. [Value of prenatal corticotherapy in the prevention of hyaline membrane disease in premature infants. Randomized prospective study]. Fekih M; Chaieb A; Sboui H; Denguezli W; Hidar S; Khairi H Tunis Med; 2002 May; 80(5):260-5. PubMed ID: 12534029 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of a single dose of antenatal steroid in surfactant-treated babies under 31 weeks' gestation. Sen S; Reghu A; Ferguson SD J Matern Fetal Neonatal Med; 2002 Nov; 12(5):298-303. PubMed ID: 12607761 [TBL] [Abstract][Full Text] [Related]
18. A retrospective analysis of the effect of antenatal steroid administration on the incidence of respiratory distress syndrome in preterm twin pregnancies. Turrentine MA; Wilson PD; Wilkins IA Am J Perinatol; 1996 Aug; 13(6):351-4. PubMed ID: 8865981 [TBL] [Abstract][Full Text] [Related]
19. The combined antenatal corticosteroids and vitamin K therapy for preventing periventricular-intraventricular hemorrhage in premature newborns less than 35 weeks gestation. Liu J; Wang Q; Zhao JH; Chen YH; Qin GL J Trop Pediatr; 2006 Oct; 52(5):355-9. PubMed ID: 16751657 [TBL] [Abstract][Full Text] [Related]
20. [The effect of surfactant therapy on the oxygen treatment of premature infants with HMD]. Iarŭkova N Akush Ginekol (Sofiia); 1998; 37(1):3-5. PubMed ID: 9770786 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]